1. Home
  2. AVNW vs NKTX Comparison

AVNW vs NKTX Comparison

Compare AVNW & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNW
  • NKTX
  • Stock Information
  • Founded
  • AVNW 2006
  • NKTX 2015
  • Country
  • AVNW United States
  • NKTX United States
  • Employees
  • AVNW N/A
  • NKTX N/A
  • Industry
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVNW Technology
  • NKTX Health Care
  • Exchange
  • AVNW Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • AVNW 283.7M
  • NKTX 235.0M
  • IPO Year
  • AVNW 2007
  • NKTX 2020
  • Fundamental
  • Price
  • AVNW $20.49
  • NKTX $3.17
  • Analyst Decision
  • AVNW Strong Buy
  • NKTX Strong Buy
  • Analyst Count
  • AVNW 4
  • NKTX 5
  • Target Price
  • AVNW $43.00
  • NKTX $18.20
  • AVG Volume (30 Days)
  • AVNW 157.8K
  • NKTX 752.0K
  • Earning Date
  • AVNW 11-08-2024
  • NKTX 11-11-2024
  • Dividend Yield
  • AVNW N/A
  • NKTX N/A
  • EPS Growth
  • AVNW N/A
  • NKTX N/A
  • EPS
  • AVNW 0.86
  • NKTX N/A
  • Revenue
  • AVNW $408,083,000.00
  • NKTX N/A
  • Revenue This Year
  • AVNW $21.01
  • NKTX N/A
  • Revenue Next Year
  • AVNW $17.87
  • NKTX N/A
  • P/E Ratio
  • AVNW $23.88
  • NKTX N/A
  • Revenue Growth
  • AVNW 18.48
  • NKTX N/A
  • 52 Week Low
  • AVNW $18.00
  • NKTX $1.90
  • 52 Week High
  • AVNW $38.85
  • NKTX $16.24
  • Technical
  • Relative Strength Index (RSI)
  • AVNW 35.72
  • NKTX 29.17
  • Support Level
  • AVNW $20.16
  • NKTX $3.25
  • Resistance Level
  • AVNW $21.30
  • NKTX $3.69
  • Average True Range (ATR)
  • AVNW 0.63
  • NKTX 0.32
  • MACD
  • AVNW -0.10
  • NKTX -0.04
  • Stochastic Oscillator
  • AVNW 3.07
  • NKTX 0.00

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures, and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: